Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Autophagy. 2024 Sep;20(9):2076-2091. doi: 10.1080/15548627.2024.2356490. Epub 2024 May 27.
The selective removal of dysfunctional mitochondria, a process termed mitophagy, is critical for cellular health and impairments have been linked to aging, Parkinson disease, and other neurodegenerative conditions. A central mitophagy pathway is orchestrated by the ubiquitin (Ub) kinase PINK1 together with the E3 Ub ligase PRKN/Parkin. The decoration of damaged mitochondrial domains with phosphorylated Ub (p-S65-Ub) mediates their elimination though the autophagy system. As such p-S65-Ub has emerged as a highly specific and quantitative marker of mitochondrial damage with significant disease relevance. Existing p-S65-Ub antibodies have been successfully employed as research tools in a range of applications including western blot, immunocytochemistry, immunohistochemistry, and enzyme-linked immunosorbent assay. However, physiological levels of p-S65-Ub in the absence of exogenous stress are very low, therefore difficult to detect and require reliable and ultrasensitive methods. Here we generated and characterized a collection of novel recombinant, rabbit monoclonal p-S65-Ub antibodies with high specificity and affinity in certain applications that allow the field to better understand the molecular mechanisms and disease relevance of PINK1-PRKN signaling. These antibodies may also serve as novel diagnostic or prognostic tools to monitor mitochondrial damage in various clinical and pathological specimens.: AD: Alzheimer disease; CCCP: carbonyl cyanide 3-chlorophenylhydrazone; ELISA: enzyme-linked immunosorbent assay; HEK293E cell: human embryonic kidney E cell; ICC: immunocytochemistry; IHC: immunohistochemistry: KO: knockout; LoB: limit of blank; LoD: limit of detection; LoQ: limit of quantification; MEF: mouse embryonic fibroblast; MSD: Meso Scale Discovery; n.s.: non-significant; nonTg: non-transgenic; PBMC: peripheral blood mononuclear cell; PD: Parkinson disease; p-S65-PRKN: phosphorylated PRKN at serine 65; p-S65-Ub: phosphorylated Ub at serine 65; Ub: ubiquitin; WT: wild-type.
功能失调的线粒体选择性去除,这一过程被称为线粒体自噬,对细胞健康至关重要,其损伤与衰老、帕金森病和其他神经退行性疾病有关。一个中央的线粒体自噬途径是由泛素(Ub)激酶 PINK1 与 E3 Ub 连接酶 PRKN/Parkin 共同协调的。用磷酸化 Ub(p-S65-Ub)修饰受损的线粒体域,通过自噬系统介导其消除。因此,p-S65-Ub 已成为线粒体损伤的高度特异性和定量标志物,与疾病有重要关联。现有的 p-S65-Ub 抗体已成功地作为研究工具应用于一系列应用中,包括 Western blot、免疫细胞化学、免疫组织化学和酶联免疫吸附测定。然而,在没有外源性应激的情况下,生理水平的 p-S65-Ub 非常低,因此难以检测,需要可靠和超灵敏的方法。在这里,我们生成并鉴定了一系列新型的重组兔单克隆 p-S65-Ub 抗体,它们在某些应用中具有高特异性和亲和力,使该领域能够更好地理解 PINK1-PRKN 信号转导的分子机制和疾病相关性。这些抗体也可能作为新型的诊断或预后工具,用于监测各种临床和病理标本中的线粒体损伤。: AD: 阿尔茨海默病; CCCP: 羰基氰化物 3-氯苯腙; ELISA: 酶联免疫吸附测定; HEK293E 细胞: 人胚肾 E 细胞; ICC: 免疫细胞化学; IHC: 免疫组织化学: KO: 敲除; LoB: 空白限; LoD: 检测限; LoQ: 定量限; MEF: 鼠胚胎成纤维细胞; MSD: Meso Scale Discovery; n.s.: 无显著差异; nonTg: 非转基因; PBMC: 外周血单核细胞; PD: 帕金森病; p-S65-PRKN: 丝氨酸 65 磷酸化 PRKN; p-S65-Ub: 丝氨酸 65 磷酸化 Ub; Ub: 泛素; WT: 野生型。